Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
oritavancin Injection [Orbactiv]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
ABSTRACT This article was written with the aim to establish a consensus clinical pathway for long-acting lipoglycopeptide… Expand
Review
2015
Review
2015
Oritavancin (Orbactiv®) is a new generation lipoglycopeptide approved for use in adult patients with acute bacterial skin and… Expand
Review
2014
Review
2014
Oritavancin (Orbactiv®) is a lipoglycopeptide antibacterial drug with activity against Gram-positive bacteria developed by The… Expand